Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hysterectomy | 2 | 2024 | 67 | 1.530 |
Why?
|
| Laparoscopy | 2 | 2021 | 472 | 0.990 |
Why?
|
| Leiomyoma | 1 | 2024 | 17 | 0.880 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 33 | 0.870 |
Why?
|
| Abdominal Neoplasms | 1 | 2021 | 22 | 0.700 |
Why?
|
| Abdominal Muscles | 1 | 2020 | 9 | 0.690 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2020 | 48 | 0.660 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 352 | 0.660 |
Why?
|
| Nerve Block | 1 | 2020 | 51 | 0.640 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 140 | 0.630 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 161 | 0.600 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 146 | 0.570 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 338 | 0.570 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2015 | 223 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 344 | 0.190 |
Why?
|
| Ischemia | 2 | 2015 | 204 | 0.190 |
Why?
|
| Neoplasm Seeding | 1 | 2021 | 3 | 0.180 |
Why?
|
| Adult | 4 | 2024 | 16675 | 0.180 |
Why?
|
| Abdominal Wall | 1 | 2021 | 23 | 0.180 |
Why?
|
| Pain Measurement | 1 | 2020 | 343 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2559 | 0.130 |
Why?
|
| Female | 4 | 2024 | 32592 | 0.130 |
Why?
|
| Middle Aged | 3 | 2024 | 17409 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 104 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2448 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2024 | 6566 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 2013 | 38 | 0.100 |
Why?
|
| Breast Diseases | 1 | 2013 | 39 | 0.100 |
Why?
|
| Operative Time | 1 | 2013 | 91 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 98 | 0.100 |
Why?
|
| Humans | 6 | 2024 | 62933 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5417 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 204 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2012 | 67 | 0.090 |
Why?
|
| Retina | 1 | 2012 | 124 | 0.090 |
Why?
|
| Mammography | 1 | 2013 | 280 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5603 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2012 | 187 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 1142 | 0.070 |
Why?
|
| Aged | 2 | 2020 | 14283 | 0.060 |
Why?
|
| Hindlimb | 2 | 2015 | 45 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2109 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 739 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 26 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2015 | 110 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 185 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2015 | 3027 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 320 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2013 | 46 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 93 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 144 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 140 | 0.020 |
Why?
|
| Chickens | 1 | 2012 | 94 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 20643 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 611 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 10833 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 892 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1618 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2158 | 0.020 |
Why?
|
| Male | 2 | 2015 | 29597 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4651 | 0.010 |
Why?
|